Cornerstone National Bank & Trust Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FlexShares Credit-Scored US Corporate Bond Index Fund
SKOR
|
+$3.3M |
| 2 |
FlexShares Credit-Scored US Long Corporate Bond Index Fund
LKOR
|
+$1.12M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$952K |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$742K |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$672K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$831K |
| 2 |
Allstate
ALL
|
+$694K |
| 3 |
FlexShares Disciplined Duration MBS Index Fund
MBSD
|
+$450K |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$174K |
| 5 |
Oracle
ORCL
|
+$4.54K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.65% |
| 2 | Financials | 2.05% |
| 3 | Healthcare | 1.97% |
| 4 | Consumer Discretionary | 1.54% |
| 5 | Industrials | 1.46% |
Similar funds
Cornerstone National Bank & Trust's Q2 2021 Portfolio in Review
As of Q2 2021, Cornerstone National Bank & Trust held 62 positions worth $229M, up 7.3% from $213M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Cornerstone National Bank & Trust deployed $8.63M of net new capital in Q2 2021, opening 1 new position and adding to 47 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 7,769 shares worth $979K.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 4.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was FlexShares Disciplined Duration MBS Index Fund, an estimated $450K trimmed.
- Cornerstone National Bank & Trust's largest Q2 2021 buy was State Street Health Care Select Sector SPDR ETF: 7,769 shares worth $979K.
- Cornerstone National Bank & Trust added most to FlexShares Credit-Scored US Corporate Bond Index Fund in Q2 2021, an estimated $3.3M increase.
- Cornerstone National Bank & Trust's biggest Q2 2021 reduction was FlexShares Disciplined Duration MBS Index Fund, cutting an estimated $450K.
- Cornerstone National Bank & Trust fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $831K.
- Cornerstone National Bank & Trust's ten largest holdings make up 77% of its $229M portfolio in Q2 2021.
- Cornerstone National Bank & Trust opened 1 new position and closed 2 in Q2 2021.
- Cornerstone National Bank & Trust's portfolio value rose 7.3% quarter-over-quarter to $229M.
Based on Cornerstone National Bank & Trust's 13F filing for Q2 2021, filed 28 Jan 2026.